You are required to be logged in to access the full website
Click here if you have forgotten your username or password
6 June 2023 - Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company focused on CNS disorders, on Tuesday announced the implementation of a stockholder-approved reverse stock split.This split will consolidate outstanding shares at a...
6 June 2023 - Israel-based dermatology company Sol-Gel Technologies (NASDAQ: SLGL) and Searchlight Pharma, a Canadian specialty pharmaceutical company, on Tuesday announced exclusive license agreements for the Canadian market for dermatology drugs, T...
6 June 2023 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Tuesday that the US Food and Drug Administration (FDA) has approved a new indication for PREVYMIS (letermovir) for the prophyl...
6 June 2023 - French biotech company OSE Immunotherapeutics (XPAR: OSE) announced on Tuesday that it presented new data on its most advanced product, Tedopi, at the ASCO 2023 Annual Meeting.Tedopi is an immunotherapy that activates tumour-specific T-...
Transgene and NEC demonstrate new positive data on individualised cancer vaccine TG4050 at ASCO 2023
6 June 2023 - Biotechnology company Transgene (Euronext Paris: TNG) and NEC Corporation (NEC; TSE: 6701), an IT and network technology company, on Tuesday reported the presentation of new immunological data on TG4050, an individualised cancer vaccine...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe